BioCentury
ARTICLE | Company News

Affibody, Swedish Orphan Biovitrum deal

May 2, 2016 7:00 AM UTC

Swedish Orphan exercised its option under a 2012 deal to develop treatments for inflammatory diseases where IL-1 is implicated. Sobi said it will have exclusive licensing rights within the interleukin...